PECORA, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 389
EU - Europa 228
AS - Asia 67
AF - Africa 53
Totale 737
Nazione #
US - Stati Uniti d'America 389
IT - Italia 82
SE - Svezia 78
SG - Singapore 36
CI - Costa d'Avorio 35
BG - Bulgaria 17
GB - Regno Unito 16
AT - Austria 14
CN - Cina 13
DE - Germania 11
NG - Nigeria 10
IN - India 8
SN - Senegal 8
HK - Hong Kong 4
VN - Vietnam 4
PL - Polonia 3
FR - Francia 2
IE - Irlanda 2
CZ - Repubblica Ceca 1
FI - Finlandia 1
JP - Giappone 1
LK - Sri Lanka 1
UA - Ucraina 1
Totale 737
Città #
Chandler 65
Fairfield 48
Abidjan 35
Ashburn 26
Seattle 26
New York 24
Woodbridge 23
Wilmington 20
Milan 18
Sofia 17
Cambridge 16
Florence 15
Vienna 14
Lawrence 12
Princeton 12
London 11
Pisa 11
Lagos 10
Ann Arbor 9
Houston 9
Singapore 9
Beijing 8
Dakar 8
Medford 7
Bremen 5
Hyderabad 5
Kent 5
Ogden 5
Boardman 4
Hong Kong 4
Piombino 4
Frankfurt am Main 3
Los Angeles 3
Ansbach 2
Changsha 2
Dublin 2
Norwalk 2
Philadelphia 2
Romainville 2
San Diego 2
Serra 2
Warsaw 2
Casaleone 1
Chiswick 1
Council Bluffs 1
Des Moines 1
Elk Grove Village 1
Formigine 1
Fulham 1
Garbagnate Milanese 1
Hefei 1
Islington 1
Jinan 1
Lappeenranta 1
Livorno 1
Massa 1
Minerbio 1
Minneapolis 1
New Delhi 1
Olomouc 1
Pietrasanta 1
Redmond 1
Redwood City 1
Rome 1
Rosignano Marittimo 1
Stuttgart 1
Vicenza 1
Vicopisano 1
Washington 1
Yokohama 1
Totale 537
Nome #
Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study 111
HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer 92
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer. 77
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 77
Immune checkpoint inhibitors in esophageal cancers: Are we finally finding the right path in the mist? 70
First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age? 60
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 45
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer 42
Combination chemotherapy in patients with advanced pancreatic cancer with an eastern cooperative oncology group performance status of 2: Lights and shadows of a frail route 39
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 37
Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158) 34
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 28
Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors 22
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer 10
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 5
The pan - COVID - AGICT study. The impact of COVID-19 pandemic on surgically treated pancreatic cancer patients. A multicentric Italian study 5
Totale 754
Categoria #
all - tutte 3.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202095 0 18 0 8 8 9 9 9 8 5 18 3
2020/202177 5 2 4 5 0 19 4 5 10 4 9 10
2021/2022115 0 0 1 3 18 25 0 3 9 11 7 38
2022/2023282 29 48 22 12 30 27 2 27 61 0 22 2
2023/2024162 14 14 22 10 18 25 12 11 3 3 12 18
2024/202518 5 13 0 0 0 0 0 0 0 0 0 0
Totale 754